Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Walgreens to show drug efficacy reports from PatientsLikeMe

Will also show alternative choices of medication

Digital pharma intelligencePatientsLikeMe has expanded its partnership with US pharmacy chain Walgreens to provide daily-updated information on why patients use specific prescriptions drugs and how effective they think they are.

The online network will also provide lists of the top five alternative medications its members have tried for the same condition and links to reports about dosage, duration and adherence for more than 5,000 medicines.

The information will be updated on a daily basis and comes from aggregated reports made by members of PatientsLikeMe.

Michael Evers, PatientsLikeMe's executive VP of marketing, technology and operations, said: “Whether you're just starting a new medication or you're researching alternatives, knowing what others have already experienced is invaluable.

“We're excited that our members are helping more people know their options and what to expect, so that everyone can make more informed choices for their health.”

Walgreens is the first pharmacy to provide this sort of information from PatientsLikeMe and the latest step expands their 2015 collaboration.

That deal saw Walgreens offer patient-reported information on side-effects and their severity on the Walgreens Health Dashboard, a secure and private personalised health information service.

6th December 2016

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics